معرفی
Prof Nathan Subramaniam is a Research Capacity Building Professor in the School of Biomedical Sciences at Queensland University of Technology (QUT), with an honorary appointment at the University of Queensland. His research focuses on liver injury, iron homeostasis, and genetic iron disorders like hereditary haemochromatosis. He leads the Hepatogenomics Research Group and has pioneered Next-Generation sequencing tools for iron-related diseases.
Education: PhD from Purdue University, postdoctoral training at UC Davis and the Institute of Molecular and Cell Biology, Singapore. Research interests include iron overload mechanisms, liver fibrosis, and co-toxicity in fatty liver diseases. He holds NHMRC Senior Research Fellowships (2012, 2017) and leads multiple Australian Competitive Grant-funded projects on iron biology and liver disorders.
Key research areas include developing novel models for iron metabolism, studying hormone transport via alpha-2-macroglobulin, and investigating the role of GNPAT in iron-overload disorders. His work integrates molecular, cellular, and animal model approaches to advance diagnostics and therapeutics.
Grants funded projects include 'Liver Injury and Iron Homeostasis' (2017-2022), 'Molecular Basis of Iron Disorders' (2012-2015), and studies on peroxisomal disorders. He collaborates internationally on projects like the EASL non-HFE Registry for ferroportin disease.
Labs/Teams: Hepatogenomics Research Group at QUT's Institute of Health and Biomedical Innovation. Supervision focuses on liver disease models, genetic modifiers of iron disorders, and TGF-beta signaling in fibrosis.
